AP-HP, Hôpital St Antoine, Paris, France.
Service d'Anatomie Pathologique, UPMC Univ Paris 06, Paris, France.
Liver Int. 2016 Nov;36(11):1668-1676. doi: 10.1111/liv.13113. Epub 2016 Mar 30.
BACKGROUND & AIMS: The contribution of liver biopsy for the diagnosis of presumed benign hepatocellular lesions lacking the diagnostic features of focal nodular hyperplasia (FNH) on magnetic resonance imaging (MRI) is unknown. We evaluated liver biopsy and MRI performances in this setting.
Magnetic resonance imaging and slides of liver biopsies performed for a presumed benign hepatocellular lesion (2006-2013) without the typical features of FNH on MRI were blindly reviewed (n = 45). Eighteen lesions were surgically removed and also analyzed. The final diagnosis was the diagnosis established after surgery or on the biopsy in the absence of surgery.
The final diagnosis was FNH (n = 19), hepatocellular adenoma (HCA, n = 15), hepatocellular carcinoma (n = 3) and indefinite (n = 4). Four lesions corresponded to non hepatocellular lesions. FNH, HNF1A mutated and inflammatory HCA were diagnosed accurately on the biopsy in 95%, 67% and 100% of the cases respectively. Diagnostic performance of liver biopsy for HNF1A mutated HCA was lower because of the lack of non-tumoral tissue. Diagnosis based on morphological analysis was certain and correct in 27 cases. Immunostaining allowed a definite diagnosis in 12 additionnal cases. Radiological diagnosis was in agreement with the histological diagnosis in 75.6% of the cases, with a very high sensitivity (97%) and specificity (100%) for the diagnosis of HNF1A mutated HCA.
Liver biopsy has a good diagnostic performance particularly for FNH and inflammatory HCA, and sampling of non-lesional tissue is highly recommended. A biopsy does not seem necessary if H-HCA is diagnosed on MRI.
对于磁共振成像(MRI)上缺乏局灶性结节性增生(FNH)特征的疑似良性肝细胞病变,肝活检对其诊断的作用尚不清楚。本研究旨在评估在这种情况下肝活检和 MRI 的表现。
对 2006 年至 2013 年间因疑似良性肝细胞病变(MRI 上无典型 FNH 特征)而行肝活检且未行手术的患者(n=45)进行回顾性分析。其中 18 例患者行手术切除并进行了分析。最终诊断为手术后或无手术情况下的活检诊断。
最终诊断为 FNH(n=19)、肝细胞腺瘤(HCA,n=15)、肝细胞癌(n=3)和不确定(n=4)。4 例病变为非肝细胞性病变。肝活检对 FNH、HNF1A 突变型 HCA 和炎症性 HCA 的诊断准确率分别为 95%、67%和 100%。由于缺乏非肿瘤性组织,HNF1A 突变型 HCA 的肝活检诊断性能较低。27 例基于形态学分析的诊断是明确且正确的。免疫组化在另外 12 例中可明确诊断。75.6%的病例中,影像学诊断与组织学诊断一致,HNF1A 突变型 HCA 的诊断具有很高的敏感性(97%)和特异性(100%)。
肝活检具有良好的诊断性能,特别是对于 FNH 和炎症性 HCA,强烈推荐对非病变组织进行取样。如果在 MRI 上诊断为 H-HCA,则似乎不需要进行活检。